Erin Hertlein, PhD
College of Medicine
Res Asst Professor
Leukemia, Lymphocytic, Chronic, B-Cell ● Cancer ● Leukemia ● Lymphoma ● Lymphoma, Mantle-Cell ● Leukemia, B-Cell ● Leukemia, Hairy Cell
Erin Hertlein, PhD, is a member of the Leukemia Research Program at the OSUCCC – James. Her research centers on NF-KB and other cancer-relevant cell signaling pathways.Dr. Hertlein is researching novel therapies that target Hsp90, EZH2, IDH proteins and other epigenetic pathways in lymphoid and myeloid diseases. She also studies the therapeutic mechanisms of these agents, including combination therapy and clinical application. Dr. Hertlein has co-authored several articles appearing in well-respected publications, such as Clinical Cancer Research, Blood and Journal of Biological Chemistry. She also has presented her research to a number of conferences, including the International Workshop on Chronic Lymphocytic Leukemia, CLL Research Consortium and American Society of Hematology.